High Court wrongly concluded public interest in cheaper drugs overrode patent holder rights, appeal court rules
There was ‘nothing unlawful’ in Biogen’s application for and exploitation of a parent patent
Biogen
Hope on the horizon for families of thousands of Alzheimer’s patients
Giving doctors access to breakthrough medicines is priority for Biogen boss Michael O’Connell in his role as Irish Pharmaceutical Healthcare Association president
Alzheimer’s drug from Eisai and Biogen gets FDA accelerated approval
Trials showed €25,000 a year drug slowed rate of cognitive decline in patients with early Alzheimer’s by 27% compared to a placebo.
US regulator broke own protocols in approving Alzheimer’s drug
Congressional report says assessment of Biogen drug was ‘rife with irregularities’
Drug firm’s injunction that would cost taxpayer €8m refused
Pharma companies sought to prevent sale of generic multiple sclerosis drug
Biogen raises annual profit forecast for second straight quarter
Investors await more data on company’s new Alzheimer’s disease drug
Pharma sector promises ‘fitter and faster’ way to get drugs to market
Incoming Ipha president says industry expects to bring 30 new medicines to market in Ireland next year but warns on patent protection
Biogen CEO to step down as company pulls back on Alzheimer’s drug
Future of Aduhelm was in doubt after Medicare restricted coverage to clinical trials
European shares rise on China economic stimulus hopes
Markets report: Cairn soars 7.2 per cent on pledge to return €95m to investors this year
Markets lifted by investor optimism and US jobs data
Tech boom leads Wall Street indices to record highs
The State’s top 10 corporate taxpayers: who are they?
Corporation tax generated €11.8 billion in receipts last year, €1 in every €5 collected
European regulators cast doubt on Biogen Alzheimer’s treatment
EMA vote deals a setback to controversial $56,000-a-year treatment
Limerick-based Kneat shifts listing to main Canadian stock exchange
Software-as-a-Service company also reports surge in third quarter revenues
European shares hit new high but Dublin and London lag
Luxury goods groups Richemont and LVMH among standout performers
European stocks reach six-week highs as Nestlé shines
Strong results from Swiss group boost food stocks, offsetting losses elsewhere
Drug company Perrigo welcomes settlement of record tax bill
Company will pay over money within seven days of formal agreement being signed
Perrigo agrees €300m settlement of €1.64bn tax assessment
Tax dispute dates back to a 2016 audit by Revenue
Moody’s says Perrigo acquisition adds to Irish tax concerns
Ratings agency turns negative on outlook for ‘over-the-counter’ medicines group over potential debt burden
Dovish ECB and upbeat earnings support euro-zone stocks
ECB pledges to keep interest rates at record lows for even longer
Perrigo boss on the largest tax bill ever issued by Revenue
Business interview: CEO Murray Kessler talks Covid and sorting out Perrigo’s Irish tax bill
Ireland's largest tax bill falls 40% to €976m
Revenue Commissioners and Perrigo have been in intense discussions for months
Like Caesar’s wife, FDA must be above suspicion
Fallout from controversial approval of Alzheimer’s drug is a concern
Europe should approach new Alzheimer’s drug with care
A decision by the US FDA to approve aducanumab has alarmed many experts
Shares buoyed by hopes ECB will keep bond-buying scheme in place
Bank shares suffer as bond yields tighten
Stocks hover close to record highs on good day for airlines
Market edgy ahead of ECB policy decision and US inflation data
Is Biogen’s new Alzheimer’s drug a breakthrough or false hope?
Medical community sharply divided on the benefits of this drug in treating dementia
Biogen will charge $56,000-a-year for Alzheimer’s drug
Price over double the highest industry analyst estimate triggers renewed criticism
US regulators approve Alzheimer’s drug from Biogen
Many scientists opposed approval of controversial treatment, saying it did not work
Revenue rejects settlement offer on €1.64bn Perrigo tax bill
Consumer healthcare group hit with largest tax assessment ever issued by commissioners
Perrigo makes offer to Revenue on disputed €1.64bn tax bill
Amount is second-largest in the history of the State, behind only high-profile Apple case
Limerick-based software company Kneat secures €14.9m in financing
Irish-founded firm is listed on Toronto Stock Exchange but is run from Limerick
Warren Buffett pulls back on banks and bets on drug makers
Billionaire investor’s Berkshire Hathaway sinks $5.7bn into four US pharma stocks
Nikkei closes at near three-decade high as Biden edges closer to win
Investors hope a gridlock in US congress would be able to stall major policy changes
Biogen shares leap after ‘substantial evidence’ Alzheimer’s drug is effective
Aducanumab targets clumps of protein that can build up in the brain
Perrigo loses action to overturn €1.64bn Irish tax assessment
Action brought by drug firm against Revenue closely watched for implications beyond case
Perrigo mulls over appeal path to pursue on €1.64bn tax bill
US pharma giant says it is disappointed by High Court judgment
High Court to rule on €1.64bn Perrigo tax case next week
Judgment could have major implications well beyond the drug company
Perrigo plans €840m Irish restructuring of old Elan unit to pay dividend
US-based drugs giant plans to reconfigure its share capital to create a distributable reserve
Pharma lobby group appoints Paul Reid as president
Irish Pharmaceutical Healthcare Association seeks State accord on access to new therapies
European stocks end week with gains for tech and telecoms
Dublin market closed marginally higher with food stocks leading the way
Apple loses €56 million of funds held in escrow as Lidl increases headcount
Seen and Heard: Funds chase Perrigo over Irish tax, hotels down €200m on weddings
A new Irish unicorn: Irish software firm Workhuman latest to be valued at over $1bn
Tech firm thought to be only the second Irish company to confirm it has hit $1bn valuation mark
European shares end lower on fears of ‘second wave’ of Covid-19
Stoxx 600 weighed down by Wirecard over missing $2.1bn in payments firm’s accounts
Revenue says Perrigo is no ‘sacrificial victim’ over €1.6bn tax bill
Drug company not being ‘singled out’ in dispute over tax assessment, High Court told
Revenue tells court it was entitled to raise €1.64bn tax assessment against Perrigo
Tax collector maintains Perrigo owes the money because of its 2013 purchase of Elan
Perrigo tells court of ‘very high level of unfairness’ in €1.64bn tax bill
Pharma group challenging ‘surprise’ Revenue assessment in hearing via video link
Perrigo’s High Court challenge to €1.64bn tax bill to be heard remotely
US drug company case to be heard via video link due to Covid-19 courtroom restrictions
Revenue faces US drug company Perrigo over disputed €1.64bn tax bill
Irish tax authorities argue sale of drug for MS should have been treated as capital gain
Irish staff of firm at centre of US coronavirus outbreak sent home
Massachusetts has reported 70 cases linked to company’s Boston conference last month
Perrigo has ‘better than 50% chance’ of winning Irish tax case
US analyst RBC upbeat about High Court challenge to €1.64bn charge over Tysabri
Workhuman considers Dublin as venue for major HR conference
Irish-founded software company reports big rise in pretax profit to $32.2m
Alzheimer’s drug hopes see Biogen shares surge 27%
Pharma group resurrects pipeline therapy it abandoned as ineffective earlier this year
Workhuman reaps $700m rewards of employee recognition
Irish software firm growing fast as organisations see benefit of workplace incentives
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices